cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA320697 | adipose tissue, white | .a | 503 to 797 | 1 to 294 | 294/294 (100 %) | 4 diff (98.7 %id) | |||
AB004854 | .a | 282 to 1159 | 1 to 878 | exact | 878/878 (100 %) | 0 diff (100 %id) | |||
AB041012 | fetal kidney | .a | 1 to 1157 | 1 to 1157 | exact | tiling clone, | 1157/1157 (100 %) | 0 diff (100 %id) | |
AB124847 | .a | 281 to 1161 | 175 to 1055 | exact | 881/1055 (83 %) | 6 diff (99.5 %id) | |||
AJ000095 | .d-u | 1 to 275 | 8 to 284 | F16L A17P T18L R19E N20T ... | tiling clone, | 284/284 (100 %) | 7 diff (97.6 %id) | ||
AJ000096 | .a | 571 to 678 | 115 to 8 | Submitted on the opposite strand | 108/120 (90 %) | 0 diff (100 %id) | |||
AK223429 | .a | 176 to 1163 | 1 to 988 | I221V V244M | AAA | 988/988 (100 %) | 3 diff (99.7 %id) | ||
AW371669 | breast | .b | 534 to 884 | 26 to 375 | tiling clone, | 350/384 (91 %) | 16 diff (95.9 %id) | ||
AW381639 | head_neck | .a | 453 to 922 | 493 to 25 | 469/501 (93 %) | 2 diff (99.7 %id) | |||
AW382928 | head_neck | .a | 571 to 952 | 382 to 3 | 380/385 (98 %) | 1 diff (99.8 %id) | |||
AW383662 | head_neck | .a | 589 to 957 | 1 to 373 | 373/376 (99 %) | 15 diff (96.1 %id) | |||
AW383663 | head_neck | .a | 560 to 881 | 322 to 1 | 322/323 (99 %) | 5 diff (98.5 %id) | |||
AW383664 | head_neck | .a | 571 to 946 | 377 to 2 | 376/380 (98 %) | 1 diff (99.8 %id) | |||
AW383665 | head_neck | .a | 560 to 924 | 364 to 1 | 364/365 (99 %) | 6 diff (98.4 %id) | |||
AW383666 | head_neck | .a | 579 to 948 | 1 to 370 | 370/370 (100 %) | 2 diff (99.5 %id) | |||
AW383667 | head_neck | .a | 583 to 957 | 1 to 375 | 375/382 (98 %) | 1 diff (99.8 %id) | |||
AW383668 | head_neck | .a | 567 to 918 | 352 to 1 | 352/363 (96 %) | 9 diff (97.6 %id) | |||
AW383669 | head_neck | .a | 565 to 948 | 1 to 384 | 384/384 (100 %) | 3 diff (99.3 %id) | |||
AW578742 | colon | .a | 445 to 1074 | 1 to 649 | 649/649 (100 %) | 37 diff (94.3 %id) | |||
AW578776 | colon | .a | 451 to 668 | 13 to 234 | 222/234 (94 %) | 10 diff (95.8 %id) | |||
BC002812 | Placenta, choriocarcinoma | .a | 194 to 1163 | 1 to 970 | exact | available from MGC, AAA | 970/970 (100 %) | 3 diff (99.7 %id) | |
BE154188 | head_neck | .a | 587 to 840 | 1 to 261 | 261/262 (99 %) | 22 diff (91.7 %id) | |||
BE154205 | head_neck | .a | 564 to 957 | 26 to 419 | 394/428 (92 %) | 9 diff (97.9 %id) | |||
BE154257 | head_neck | .a | 598 to 960 | 373 to 15 | Submitted on the opposite strand | 359/373 (96 %) | 0 diff (100 %id) | ||
BE775303 | uterus | .a | 563 to 1083 | 44 to 564 | 521/565 (92 %) | 7 diff (98.8 %id) | |||
BF086996 | head_neck | .a | 564 to 954 | 401 to 14 | 388/403 (96 %) | 5 diff (98.8 %id) | |||
BF350709 | head_neck | .a | 567 to 948 | 3 to 385 | 383/385 (99 %) | 9 diff (97.7 %id) | |||
BF985072 | uterus | .b | 113 to 488 | 1 to 376 | 376/377 (99 %) | 8 diff (97.9 %id) | |||
BF997401 | placenta_normal | .b | 443 to 650 | 1 to 208 | tiling clone, | 208/211 (98 %) | 12 diff (94.4 %id) | ||
BP205253 | coronary artery | .a | 571 to 1122 | 1 to 550 | 550/550 (100 %) | 8 diff (98.6 %id) | |||
CN262093 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 195 to 779 | 1 to 585 | 585/585 (100 %) | 3 diff (99.5 %id) | |||
CR541709 | .a | 282 to 1112 | 1 to 831 | 831/831 (100 %) | 2 diff (99.8 %id) | ||||
CR747437 | melanotic melanoma, skin | .a | 156 to 661 | 12 to 517 | 506/517 (97 %) | 6 diff (98.9 %id) | |||
CU455874 | epidermis | .a | 544 to 1160 | 624 to 7 | Submitted on the opposite strand | 618/625 (98 %) | 0 diff (100 %id) | ||
CV026299 | mixed | .a | 282 to 725 | 1 to 444 | 444/444 (100 %) | 2 diff (99.6 %id) | |||
DW444418 | Liver | .b | 399 to 607 | 17 to 225 | 209/226 (92 %) | 10 diff (95.6 %id) | |||
ES311274 | frontal balding hair, skin | .a | 205 to 364 | 1 to 159 | 159/159 (100 %) | 1 diff (99.4 %id) | |||
DA504156 | brain | .c-u | 1 to 549 | 2 to 550 | C4Y G136E | tiling clone, capped | 549/549 (100 %) | 4 diff (99.3 %id) | |
AA070863 | .b | 187 to 569 | 380 to 1 | 380/381 (99 %) | 4 diff (99.0 %id) | ||||
AA071157 | .b | 164 to 289 | 1 to 126 | 126/126 (100 %) | 0 diff (100 %id) | ||||
AB004850 | lung | .a | 630 to 1159 | 8 to 537 | 530/530 (100 %) | 0 diff (100 %id) | |||
AA887663 | colon, colon tumor RER+ | .b | 162 to 600 | 435 to 1 | 435/435 (100 %) | 7 diff (98.4 %id) | |||
AI352345 | pooled germ cell tumors | .b | 175 to 596 | 422 to 1 | tiling clone, | 422/422 (100 %) | 0 diff (100 %id) | ||
AI375520 | .b | 137 to 597 | 474 to 14 | AAA | 461/461 (100 %) | 1 diff (99.8 %id) | |||
AI658832 | Prostate | .a | 321 to 1159 | 844 to 1 | 844/844 (100 %) | 18 diff (97.9 %id) | |||
AI686685 | Prostate | .b | 1 to 601 | 601 to 1 | G3S P6Q M7W P33R T139K | tiling clone, | 601/783 (76 %) | 7 diff (99.2 %id) | |
AI652553 | pooled germ cell tumors | .b | 162 to 607 | 447 to 2 | 446/447 (99 %) | 0 diff (100 %id) | |||
AI830785 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .a | 371 to 1069 | 786 to 91 | 696/786 (88 %) | 34 diff (95.7 %id) | |||
AW450998 | .b | 163 to 597 | 452 to 18 | AAA | 435/435 (100 %) | 3 diff (99.4 %id) | |||
BE385454 | melanotic melanoma, skin | .a | 214 to 737 | 1 to 517 | 517/518 (99 %) | 12 diff (97.7 %id) | |||
BE408293 | choriocarcinoma, placenta | .a | 213 to 886 | 1 to 670 | 670/724 (92 %) | 10 diff (98.7 %id) | |||
BE727298 | melanotic melanoma, skin | .a | 214 to 871 | 1 to 662 | 662/662 (100 %) | 13 diff (98.1 %id) | |||
BF476779 | sympathetic trunk | .b | 116 to 603 | 489 to 1 | 489/627 (77 %) | 27 diff (95.7 %id) | |||
BG165774 | hypernephroma, cell line, Kidney | .a | 196 to 1021 | 1 to 806 | 806/977 (82 %) | 33 diff (96.7 %id) | |||
BG340163 | leiomyosarcoma cell line, uterus | .a | 184 to 662 | 1 to 485 | 485/758 (63 %) | 18 diff (97.7 %id) | |||
BG714047 | brain, hypothalamus | .a | 70 to 872 | 1 to 805 | 805/805 (100 %) | 12 diff (98.6 %id) | |||
BG765305 | melanotic melanoma, high MDR (cell line), skin | .a | 192 to 892 | 1 to 694 | 694/694 (100 %) | 13 diff (98.2 %id) | |||
BI083816 | epidermoid carcinoma, cell line, salivary gland | .a | 54 to 639 | 1 to 585 | fully sequenced, | 585/585 (100 %) | 3 diff (99.5 %id) | ||
BI084483 | epidermoid carcinoma, cell line, salivary gland | .a | 609 to 892 | 284 to 1 | fully sequenced, | 284/284 (100 %) | 0 diff (100 %id) | ||
BU150098 | melanotic melanoma, cell line, skin | .a | 293 to 1047 | 1 to 759 | 759/915 (82 %) | 23 diff (97.5 %id) | |||
BQ440869 | melanotic melanoma, skin | .a | 158 to 1029 | 1 to 884 | 884/950 (93 %) | 25 diff (97.4 %id) | |||
BQ717030 | sympathetic trunk | .a | 167 to 683 | 1 to 519 | 519/1007 (51 %) | 8 diff (99.3 %id) | |||
BQ669678 | epidermoid carcinoma, cell line, salivary gland | .a | 425 to 1168 | 1 to 743 | AAA | 743/743 (100 %) | 7 diff (99.1 %id) | ||
AU099899 | .a | 176 to 475 | 1 to 300 | 300/300 (100 %) | 5 diff (98.4 %id) | ||||
BP273099 | .a | 176 to 729 | 1 to 554 | 554/554 (100 %) | 10 diff (98.2 %id) | ||||
CB159246 | Liver | .a | 532 to 1049 | 1 to 518 | 518/518 (100 %) | 0 diff (100 %id) | |||
AI752750 | Bone, Hip | .a | 137 to 558 | 13 to 434 | 422/434 (97 %) | 6 diff (98.7 %id) | |||
NM_001236.3 | .a | 54 to 1163 | 1 to 1110 | exact | RefSeq, AAA | 1110/1110 (100 %) | 0 diff (100 %id) | ||
BM742659 | Ascites, stomach | .a | 182 to 756 | 1 to 575 | 575/575 (100 %) | 3 diff (99.5 %id) | |||
BM765037 | Ascites, stomach | .a | 175 to 825 | 1 to 650 | 650/650 (100 %) | 4 diff (99.4 %id) | |||
BM772797 | Ascites, stomach | .a | 175 to 744 | 1 to 570 | 570/570 (100 %) | 3 diff (99.5 %id) | |||
BM762172 | myeloma | .a | 159 to 553 | 1 to 395 | 395/395 (100 %) | 2 diff (99.5 %id) | |||
BM763268 | myeloma | .a | 159 to 802 | 1 to 644 | 644/644 (100 %) | 5 diff (99.3 %id) | |||
TI_1948102863 | .a | 281 to 1114 | 134 to 974 | 841/1352 (62 %) | 42 diff (96.9 %id) | ||||
TI_1948103021 | .a | 284 to 1119 | 141 to 979 | fully sequenced, | 839/979 (85 %) | 48 diff (95.1 %id) | |||
TI_1948103022 | .a | 883 to 1122 | 371 to 130 | fully sequenced, | 242/371 (65 %) | 6 diff (98.4 %id) | |||
TI_1948103187 | .a | 281 to 1118 | 135 to 986 | V203S S205I R206E I207D L208P ... | fully sequenced, | 852/986 (86 %) | 46 diff (95.4 %id) | ||
TI_1948103188 | .a | 927 to 1121 | 330 to 133 | fully sequenced, | 198/330 (60 %) | 6 diff (98.2 %id) | |||
TI_1948103349 | .a | 281 to 1117 | 131 to 971 | F175V V176C E177G D178G T179H ... | fully sequenced, | 841/971 (86 %) | 35 diff (96.4 %id) | ||
TI_1948103350 | .a | 884 to 1122 | 344 to 105 | fully sequenced, | 240/344 (69 %) | 7 diff (98.0 %id) | |||
CN479593 | Chondrosarcoma, Left Pubic Bone | .a | 446 to 1163 | 736 to 19 | AAA | 718/718 (100 %) | 2 diff (99.8 %id) | ||
BU629438 | cell lines, Chondrosarcoma | .a | 372 to 1167 | 813 to 19 | tiling clone, AAA | 795/795 (100 %) | 6 diff (99.3 %id) | ||
AI752750 | Bone, Hip | .a | 137 to 558 | 13 to 434 | 422/434 (97 %) | 6 diff (98.7 %id) | |||
AI752750 | Bone, Hip | .a | 137 to 558 | 13 to 434 | 422/434 (97 %) | 6 diff (98.7 %id) | |||
NM_001236.3 | NM_001236 | CBR3.aAug10 | 1163 | 1110 | NM_001236 | 1110 | 0 | ||
BM742659 | S3SNU16-9-E07 | CBR3.aAug10 | 756 | 575 | S3SNU16-9-E07 | 575 | 3 | ||
BM742659 | S3SNU16-9-E07 | CBR3.aAug10 | 756 | 575 | S3SNU16-9-E07 | 575 | 3 | ||
BM765037 | S3SNU16s1-11-D11 | CBR3.aAug10 | 825 | 650 | S3SNU16s1-11-D11 | 650 | 4 | ||
BM765037 | S3SNU16s1-11-D11 | CBR3.aAug10 | 825 | 650 | S3SNU16s1-11-D11 | 650 | 4 | ||
BM772797 | S3SNU16s1-22-H02 | CBR3.aAug10 | 744 | 570 | S3SNU16s1-22-H02 | 570 | 3 | ||
BM772797 | S3SNU16s1-22-H02 | CBR3.aAug10 | 744 | 570 | S3SNU16s1-22-H02 | 570 | 3 | ||
BM762172 | S13KMS5-10-C12 | CBR3.aAug10 | 553 | 395 | S13KMS5-10-C12 | 395 | 2 | ||
BM763268 | S13KMS5-19-G05 | CBR3.aAug10 | 802 | 644 | S13KMS5-19-G05 | 644 | 5 | ||
TI_1948102863 | SC_11050_1_B6 | CBR3.aAug10 | 1114 | 974 | SC_11050_1_B6 | 841 | 42 | ||
TI_1948103021 | SC_11050_2_B6 | CBR3.aAug10 | 1119 | 979 | SC_11050_2_B6 | 839 | 48 | ||
TI_1948103022 | SC_11050_2_B6 | CBR3.aAug10 | 1122 | 130 | SC_11050_2_B6 | 242 | 6 | ||
TI_1948103187 | SC_11050_3_B6 | CBR3.aAug10 | 1118 | 986 | SC_11050_3_B6 | 852 | 46 | ||
TI_1948103188 | SC_11050_3_B6 | CBR3.aAug10 | 1121 | 133 | SC_11050_3_B6 | 198 | 6 | ||
TI_1948103349 | SC_11050_4_B6 | CBR3.aAug10 | 1117 | 971 | SC_11050_4_B6 | 841 | 35 | ||
TI_1948103350 | SC_11050_4_B6 | CBR3.aAug10 | 1122 | 105 | SC_11050_4_B6 | 240 | 7 | ||
CN479593 | UI-H-ED1-ayb-l-05-0-UI | CBR3.aAug10 | 1163 | 19 | UI-H-ED1-ayb-l-05-0-UI | 718 | 2 | ||
CN479593 | UI-H-ED1-ayb-l-05-0-UI | CBR3.aAug10 | 1163 | 19 | UI-H-ED1-ayb-l-05-0-UI | 718 | 2 | ||
BU629438 | UI-H-FL0-bdj-i-07-0-UI | CBR3.aAug10 | 1167 | 19 | UI-H-FL0-bdj-i-07-0-UI | 795 | 6 | ||
BU629438 | UI-H-FL0-bdj-i-07-0-UI | CBR3.aAug10 | 1167 | 19 | UI-H-FL0-bdj-i-07-0-UI | 795 | 6 |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c-u, .d-u | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes DCI |